SOPHiA GENETICS (SOPH) Total Non-Current Liabilities (2020 - 2026)

SOPHiA GENETICS has reported Total Non-Current Liabilities for 6 years, with the latest figure at $65.4 million in Q4 2025.

• Quarterly Total Non-Current Liabilities rose 104.14% year-over-year to $65.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65.4 million (up 104.14% YoY) and the FY2025 annual result came in at $65.4 million, up 104.14% from the prior year.
• Total Non-Current Liabilities fell to $65.4 million in Q4 2025 per SOPH's latest filing, from $65.8 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $66.4 million in Q2 2025 and troughed at $8.0 million in Q2 2021.
• A 5-year average of $27.8 million and a median of $18.5 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The widest YoY moves for Total Non-Current Liabilities: up 125.7% in 2022, down 4.65% in 2022.
• Over 5 years, Total Non-Current Liabilities stood at $16.2 million in 2021, then increased by 4.5% to $16.9 million in 2022, then increased by 12.99% to $19.1 million in 2023, then jumped by 67.68% to $32.0 million in 2024, then soared by 104.14% to $65.4 million in 2025.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $65.4 million, $65.8 million, and $66.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.